These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 26325475)

  • 1. A novel variable antibody fragment dimerized by leucine zippers with enhanced neutralizing potency against rabies virus G protein compared to its corresponding single-chain variable antibody fragment.
    Li Z; Cheng Y; Xi H; Gu T; Yuan R; Chen X; Jiang C; Kong W; Wu Y
    Mol Immunol; 2015 Dec; 68(2 Pt A):168-75. PubMed ID: 26325475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering of a novel zipFv using leucine zipper motif against rabies virus glycoprotein G with improved protection potency in vivo.
    Xi H; Zhang K; Yin Y; Gu T; Sun Q; Li Z; Cheng Y; Jiang C; Kong W; Wu Y
    Immunol Lett; 2017 Jun; 186():9-14. PubMed ID: 28389318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative effects of a disulfide bond mismatch in anti-rabies G protein single-chain antibody variable fragment FV57.
    Duan Y; Gu T; Zhang X; Jiang C; Yuan R; Li Z; Wang D; Chen X; Wu C; Chen Y; Wu Y; Kong W
    Mol Immunol; 2014 Jun; 59(2):136-41. PubMed ID: 24598312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel disulfide-stabilized single-chain variable antibody fragment against rabies virus G protein with enhanced in vivo neutralizing potency.
    Duan Y; Gu TJ; Jiang CL; Yuan RS; Zhang HF; Hou HJ; Yu XH; Chen Y; Zhang Y; Wu YG; Kong W
    Mol Immunol; 2012 Jun; 51(2):188-96. PubMed ID: 22484084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A VL-linker-VH Orientation Dependent Single Chain Variable Antibody Fragment Against Rabies Virus G Protein with Enhanced Neutralizing Potency in vivo.
    Cheng Y; Li Z; Xi H; Gu T; Yuan R; Chen X; Jiang C; Kong W; Wu Y
    Protein Pept Lett; 2016; 23(1):24-32. PubMed ID: 26497316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency.
    Turki I; Hammami A; Kharmachi H; Mousli M
    Mol Immunol; 2014 Feb; 57(2):66-73. PubMed ID: 24091293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion Peptide Improves Stability and Bioactivity of Single Chain Antibody against Rabies Virus.
    Xi H; Zhang K; Yin Y; Gu T; Sun Q; Shi L; Zhang R; Jiang C; Kong W; Wu Y
    J Microbiol Biotechnol; 2017 Apr; 27(4):718-724. PubMed ID: 28068664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single domain antibody multimers confer protection against rabies infection.
    Boruah BM; Liu D; Ye D; Gu TJ; Jiang CL; Qu M; Wright E; Wang W; He W; Liu C; Gao B
    PLoS One; 2013; 8(8):e71383. PubMed ID: 23977032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression, purification and characterization of a human single-chain Fv antibody fragment fused with the Fc of an IgG1 targeting a rabies antigen in Pichia pastoris.
    Wang DD; Su MM; Sun Y; Huang SL; Wang J; Yan WQ
    Protein Expr Purif; 2012 Nov; 86(1):75-81. PubMed ID: 22982755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein.
    Sun L; Chen Z; Yu L; Wei J; Li C; Jin J; Shen X; Lv X; Tang Q; Li D; Liang M
    Appl Microbiol Biotechnol; 2012 Oct; 96(2):357-66. PubMed ID: 22678022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Generation of Human ScFv Antibodies for Antigenic Site III of Rabies Virus Glycoprotein from Antibody-phage Libraries by Chain Shuffling].
    Sun L; Liu Y; Li C; Li D; Liang M
    Bing Du Xue Bao; 2016 Jul; 32(4):393-8. PubMed ID: 29979522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction and detection the bioactivity of human anti-rabies virus scdsFv].
    Yang R; Yang S; Wang C; Gao Y; Shan H; Xia X
    Wei Sheng Wu Xue Bao; 2011 Jan; 51(1):98-104. PubMed ID: 21465795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of Recombinant Human Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis].
    Sun L; Liu Y; Li C; Li D; Liang M
    Bing Du Xue Bao; 2016 Jul; 32(4):399-403. PubMed ID: 29979531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of recombinant single-chain antibodies neutralizing the cytolytic activity of vaginolysin, the main virulence factor of Gardnerella vaginalis.
    Pleckaityte M; Mistiniene E; Lasickiene R; Zvirblis G; Zvirbliene A
    BMC Biotechnol; 2011 Nov; 11():100. PubMed ID: 22047084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
    Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B
    Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of the human neutralizing antibody fragment Fab091 against rabies virus.
    Li C; Zhang F; Lin H; Wang ZC; Liu XJ; Feng ZQ; Zhu J; Guan XH
    Acta Pharmacol Sin; 2011 Mar; 32(3):329-37. PubMed ID: 21278782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel strategy for expression and characterization of rabies virus glycoprotein.
    Zhao R; Shan Y; Li M; Lou Z; Feng Y; Huang L; Ren W; Wang P; Sun Y; Sun Y; Su J; Sun H; Hong D; Li Y; Chen R; Sun L
    Protein Expr Purif; 2020 Apr; 168():105567. PubMed ID: 31904423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.
    Bakker AB; Marissen WE; Kramer RA; Rice AB; Weldon WC; Niezgoda M; Hanlon CA; Thijsse S; Backus HH; de Kruif J; Dietzschold B; Rupprecht CE; Goudsmit J
    J Virol; 2005 Jul; 79(14):9062-8. PubMed ID: 15994800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic variations of recent street rabies virus.
    Wang W; Ma J; Nie J; Li J; Cao S; Wang L; Yu C; Huang W; Li Y; Yu Y; Liang M; Zirkle B; Chen XS; Li X; Kong W; Wang Y
    Emerg Microbes Infect; 2019; 8(1):1584-1592. PubMed ID: 31682199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An inactivated recombinant rabies CVS-11 virus expressing two copies of the glycoprotein elicits a higher level of neutralizing antibodies and provides better protection in mice.
    Xue XH; Zheng XX; Wang HL; Ma JZ; Li L; Gai WW; Wang TC; Yang ST; Xia XZ
    Virus Genes; 2014 Jun; 48(3):411-20. PubMed ID: 24535572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.